RxNorm Semantic Concepts Index - 910
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "910".
RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
---|---|---|---|---|
RxCUI: 910 | Heterophile antibody | Designated preferred name (PT) | NO | |
RxCUI: 910 | Heterophile antibody | Full form of descriptor (FN) | NO | |
RxCUI: 910 | Heterophile antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 9100 | Methionine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 9100 | Methionine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 9100 | Methionine | Full form of descriptor (FN) | NO | |
RxCUI: 9100 | Methionine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 9100 | Methionine | Designated preferred name (PT) | NO | |
RxCUI: 91000 | O-methyl-bufotenine | Designated preferred name (PT) | NO | |
RxCUI: 91000 | O-methyl-bufotenine | Full form of descriptor (FN) | NO | |
RxCUI: 91001 | Triturus species toxin | Designated preferred name (PT) | NO | |
RxCUI: 91001 | Triturus species toxin | Full form of descriptor (FN) | NO | |
RxCUI: 91004 | Candicin toxin | Designated preferred name (PT) | NO | |
RxCUI: 91004 | Candicin toxin | Full form of descriptor (FN) | NO | |
RxCUI: 91005 | Leptodactylin | Designated preferred name (PT) | NO | |
RxCUI: 91005 | Leptodactylin | Full form of descriptor (FN) | NO | |
RxCUI: 91006 | Zetekitoxin | Designated preferred name (PT) | NO | |
RxCUI: 91006 | Zetekitoxin | Full form of descriptor (FN) | NO | |
RxCUI: 91007 | Samarandin toxin | Designated preferred name (PT) | NO | |
RxCUI: 91007 | Samarandin toxin | Full form of descriptor (FN) | NO | |
RxCUI: 91009 | Short neurotoxin venom | Designated preferred name (PT) | NO | |
RxCUI: 91009 | Short neurotoxin venom | Full form of descriptor (FN) | NO | |
RxCUI: 91010 | Long neurotoxin venom | Designated preferred name (PT) | NO | |
RxCUI: 91010 | Long neurotoxin venom | Full form of descriptor (FN) | NO | |
RxCUI: 91011 | Augusticeps-type venom | Designated preferred name (PT) | NO | |
RxCUI: 91011 | Augusticeps-type venom | Full form of descriptor (FN) | NO | |
RxCUI: 91012 | Cardiotoxin venom | Designated preferred name (PT) | NO | |
RxCUI: 91012 | Cardiotoxin venom | Full form of descriptor (FN) | NO | |
RxCUI: 91013 | Cytotoxin venom | Designated preferred name (PT) | NO | |
RxCUI: 91013 | Cytotoxin venom | Full form of descriptor (FN) | NO | |
RxCUI: 91014 | Hemolysin venom | British preferred term (PTGB) | NO | |
RxCUI: 91014 | Hemolysin venom | Designated preferred name (PT) | NO | |
RxCUI: 91014 | Hemolysin venom | Full form of descriptor (FN) | NO | |
RxCUI: 91015 | Phospholipase A venom | Designated preferred name (PT) | NO | |
RxCUI: 91015 | Phospholipase A venom | Full form of descriptor (FN) | NO | |
RxCUI: 91016 | Protease inhibitor venom | Designated preferred name (PT) | NO | |
RxCUI: 91016 | Protease inhibitor venom | Full form of descriptor (FN) | NO | |
RxCUI: 91017 | Crotamine venom | Designated preferred name (PT) | NO | |
RxCUI: 91017 | Crotamine venom | Full form of descriptor (FN) | NO | |
RxCUI: 91018 | Tetramine toxin | Designated preferred name (PT) | NO | |
RxCUI: 91018 | Tetramine toxin | Full form of descriptor (FN) | NO | |
RxCUI: 91019 | Bacterial agent | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 91019 | Bacterial agent | Full form of descriptor (FN) | NO | |
RxCUI: 91019 | Bacterial agent | Designated preferred name (PT) | NO | |
RxCUI: 91020 | Bacteriopurpurin | Designated preferred name (PT) | NO | |
RxCUI: 91020 | Bacteriopurpurin | Full form of descriptor (FN) | NO | |
RxCUI: 91021 | Cadaveric alkaloid | Designated preferred name (PT) | NO | |
RxCUI: 91021 | Cadaveric alkaloid | Full form of descriptor (FN) | NO | |
RxCUI: 91021 | Cadaveric alkaloid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 91021 | Cadaveric alkaloid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 91021 | Cadaveric alkaloid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 91021 | Cadaveric alkaloid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 91022 | Neurine | Designated preferred name (PT) | NO | |
RxCUI: 91022 | Neurine | Full form of descriptor (FN) | NO | |
RxCUI: 91023 | Ptomatropine | Designated preferred name (PT) | NO | |
RxCUI: 91023 | Ptomatropine | Full form of descriptor (FN) | NO | |
RxCUI: 91024 | Septicine | Designated preferred name (PT) | NO | |
RxCUI: 91024 | Septicine | Full form of descriptor (FN) | NO | |
RxCUI: 91025 | Animal oil | Designated preferred name (PT) | NO | |
RxCUI: 91025 | Animal oil | Full form of descriptor (FN) | NO | |
RxCUI: 91030 | Drug diluent | Designated preferred name (PT) | NO | |
RxCUI: 91030 | Drug diluent | Full form of descriptor (FN) | NO | |
RxCUI: 91058 | Chewable Tablet | Dose Form (DF) | YES | |
RxCUI: 91060 | Caplet | Dose Form (DF) | NO | |
RxCUI: 91063 | Tripelennamine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 91063 | Tripelennamine hydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 91063 | Tripelennamine hydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 91065 | Bromazine hydrochloride | British preferred term (PTGB) | NO | |
RxCUI: 91065 | Bromazine hydrochloride | Full form of descriptor (FN) | NO | |
RxCUI: 91065 | Bromazine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 91065 | Bromazine hydrochloride | Designated preferred name (PT) | NO | |
RxCUI: 91066 | Carbinoxamine maleate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 91066 | Carbinoxamine maleate | Designated preferred name (PT) | YES | |
RxCUI: 91066 | Carbinoxamine maleate | Full form of descriptor (FN) | YES | |
RxCUI: 91070 | Buclizine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 91070 | Buclizine hydrochloride | Designated preferred name (PT) | NO | |
RxCUI: 91070 | Buclizine hydrochloride | Full form of descriptor (FN) | NO | |
RxCUI: 91071 | Cyclizine lactate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 91071 | Cyclizine lactate | Designated preferred name (PT) | NO | |
RxCUI: 91071 | Cyclizine lactate | Full form of descriptor (FN) | NO | |
RxCUI: 91073 | Pentamidine diisothionate | Designated preferred name (PT) | NO | |
RxCUI: 91073 | Pentamidine diisothionate | Full form of descriptor (FN) | NO | |
RxCUI: 91074 | Bacitracin C | Designated preferred name (PT) | NO | |
RxCUI: 91074 | Bacitracin C | Full form of descriptor (FN) | NO | |
RxCUI: 91075 | Clindamycin palmitate hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 91075 | Clindamycin palmitate hydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 91075 | Clindamycin palmitate hydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 91077 | Griseofulvin microsize | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 91077 | Griseofulvin microsize | Designated preferred name (PT) | NO | |
RxCUI: 91077 | Griseofulvin microsize | Full form of descriptor (FN) | NO | |
RxCUI: 91078 | Griseofulvin ultramicrosize | Designated preferred name (PT) | NO | |
RxCUI: 91078 | Griseofulvin ultramicrosize | Full form of descriptor (FN) | NO | |
RxCUI: 91079 | First generation cephalosporin | Designated preferred name (PT) | NO | |
RxCUI: 91079 | First generation cephalosporin | Full form of descriptor (FN) | NO | |
RxCUI: 91079 | First generation cephalosporin | Designated preferred name (PT) | NO | |
RxCUI: 91079 | First generation cephalosporin | Full form of descriptor (FN) | NO | |
RxCUI: 91080 | Ultracef | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 91081 | Second generation cephalosporin | Full form of descriptor (FN) | NO | |
RxCUI: 91081 | Second generation cephalosporin | Designated preferred name (PT) | NO | |
RxCUI: 91081 | Second generation cephalosporin | Full form of descriptor (FN) | NO | |
RxCUI: 91081 | Second generation cephalosporin | Designated preferred name (PT) | NO | |
RxCUI: 91082 | Third generation cephalosporin | Full form of descriptor (FN) | NO | |
RxCUI: 91082 | Third generation cephalosporin | Designated preferred name (PT) | NO | |
RxCUI: 91082 | Third generation cephalosporin | Full form of descriptor (FN) | NO | |
RxCUI: 91082 | Third generation cephalosporin | Designated preferred name (PT) | NO | |
RxCUI: 91083 | Natural penicillin | Full form of descriptor (FN) | NO | |
RxCUI: 91083 | Natural penicillin | Designated preferred name (PT) | NO | |
RxCUI: 91083 | Natural penicillin | Full form of descriptor (FN) | NO | |
RxCUI: 91083 | Natural penicillin | Designated preferred name (PT) | NO | |
RxCUI: 91084 | Aminopenicillin | Designated preferred name (PT) | NO | |
RxCUI: 91084 | Aminopenicillin | Full form of descriptor (FN) | NO | |
RxCUI: 91084 | Aminopenicillin | Designated preferred name (PT) | NO | |
RxCUI: 91084 | Aminopenicillin | Full form of descriptor (FN) | NO | |
RxCUI: 91085 | Alpha-carboxypenicillin | Designated preferred name (PT) | NO | |
RxCUI: 91085 | Alpha-carboxypenicillin | Full form of descriptor (FN) | NO | |
RxCUI: 91085 | Alpha-carboxypenicillin | Designated preferred name (PT) | NO | |
RxCUI: 91085 | Alpha-carboxypenicillin | Full form of descriptor (FN) | NO | |
RxCUI: 91086 | Acylaminopenicillin | Designated preferred name (PT) | NO | |
RxCUI: 91086 | Acylaminopenicillin | Full form of descriptor (FN) | NO | |
RxCUI: 91086 | Acylaminopenicillin | Designated preferred name (PT) | NO | |
RxCUI: 91086 | Acylaminopenicillin | Full form of descriptor (FN) | NO | |
RxCUI: 91089 | Nitrofurantoin sodium | Designated preferred name (PT) | NO | |
RxCUI: 91089 | Nitrofurantoin sodium | Full form of descriptor (FN) | NO | |
RxCUI: 91091 | Antimony sodium thioglycolate | Designated preferred name (PT) | NO | |
RxCUI: 91091 | Antimony sodium thioglycolate | Full form of descriptor (FN) | NO | |
RxCUI: 91092 | Antimony thioglycolate | Designated preferred name (PT) | NO | |
RxCUI: 91092 | Antimony thioglycolate | Full form of descriptor (FN) | NO | |
RxCUI: 91094 | Hydroxystilbamidine isethionate | Designated preferred name (PT) | NO | |
RxCUI: 91094 | Hydroxystilbamidine isethionate | Full form of descriptor (FN) | NO | |
RxCUI: 91095 | Oxophenarsine hydrochloride | Designated preferred name (PT) | NO | |
RxCUI: 91095 | Oxophenarsine hydrochloride | Full form of descriptor (FN) | NO | |
RxCUI: 91099 | Thiosalicylate | Full form of descriptor (FN) | NO | |
RxCUI: 91099 | Thiosalicylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 91099 | Thiosalicylate | Designated preferred name (PT) | NO | |
RxCUI: 91099 | Thiosalicylate | Full form of descriptor (FN) | NO | |
RxCUI: 91099 | Thiosalicylate | Designated preferred name (PT) | NO |